SCN5A and trigeminal nerve disorder: Carbamazepine is a first-line widely used anticonvulsant for the treatment of epilepsy and pain associated with trigeminal neuralgia, and works via inhibition of sodium channel protein type 5 subunit alpha (SCN5A)32 and ATP-sensitive potassium (KATP) channels33.